Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Percutaneous vertebroplasty with retrolaminar block for osteoporotic vertebral compression fractures
ChiCTR2600117226Phase 4Not yet recruiting
- Sponsor
- Guangyuan First People's Hospital
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in vertebral compression fracture (VCF) (2 arms), sponsored by Guangyuan First People's Hospital. Primary endpoint: Resting and active (turning over) visual analog scale (VAS) scores. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
vertebral compression fracture (VCF)
Beyond the preview
Go deeper on ChiCTR2600117226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117226.